Sentence examples for challenge of variability from inspiring English sources

Despite the continuing challenge of variability, reports are gradually becoming more consistent across sections.

The evaluation study was set out to be a baseline that addressed the challenge of variability and examined inclusiveness, pedagogy, architecture and services, participation and governance, systemic management, and cost.

In order to provide a more comprehensive treatment of DSPL models and their solution architectures, in this research work we provide an overview of the state of the art and current techniques that, partially, attempt to face the many challenges of runtime variability mechanisms in the context of Dynamic Software Product Lines.

However, neither strategy (alone or in combination) has resolved the persistent challenges of rater variability.

However, neither strategy alone or in combination, has resolved the persistent challenges of interviewer variability, and there is a need for novel evidence-based approaches, which have so far been discussed in the context of work-based assessment around rater cognition [ 37- 39].

'Life styles' of desert biota are adapted to meet the never-ending challenge of extreme temporal variability and unpredictability in a resource-deficient landscape with small, isolated pockets of rich resources.

One of the major challenges is the high degree of variability in L1 methylation between the evaluated samples [ 57].

Challenges include variability of EBC production between individuals, the lack of a marker of dilution, and potential influence of different collection devices [18].

Different reference populations for the calculation of BMI SD score make comparisons between studies challenging, and variability of BMI SD score depends on the child's level of adiposity.

These multiple layers of variability pose a significant challenge to the statistical methods applied in meta-analyses.

This is of particular concern in light of the challenge of diagnosing IBS and the variability in subtype symptomatology, and both the FDA and European Medicines Agency have suggested that patient reported outcome (PRO) instruments specific to particular IBS subtypes may be potentially necessary to measure effectively the therapeutic benefit.